文献速递慢性肾脏病

利用多机构电子健康记录数据库评估慢性肾脏病患儿的肾功能下降

Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-01-18

本研究基于美国六家儿科健康系统的电子健康记录数据,回顾性识别了2009年1月1日至2022年2月28日期间11,240例慢性肾脏病(CKD)患儿,评估CKD进展并分析肾功能下降的临床危险因素。中位随访5.1年,发现较低eGFR分类、肾小球疾病、恶性肿瘤、蛋白尿、高血压、复杂慢性共病数量、男性及较小年龄与CKD进展相关。

要点

  • 在7,148,875名儿童中识别出11,240例CKD患儿(每10,000人15.7例),中位年龄11岁,50%为女性。
  • 中位随访5.1年,中位初始eGFR为75.3 ml/min per 1.73 m2,37%有蛋白尿,35%有高血压。
  • eGFR 15-29 ml/min per 1.73 m2组进展风险最高(aHR 5.75,95%CI 5.05-6.55),蛋白尿合并高血压aHR 3.98(95%CI 3.40-4.68)。

核心结论

  • 在儿童CKD大规模真实世界数据中,疾病病因、白蛋白尿、高血压、年龄、男性、较低eGFR及随访开始时较大的医疗复杂性均与肾功能下降更快相关。

研究设计与样本

  • 回顾性队列研究,数据来自美国PEDSnet六家儿科健康系统,纳入2009年1月1日至2022年2月28日期间就诊的18个月至18岁儿童,CKD定义为两次eGFR<90且≥15 ml/min per 1.73 m2、间隔≥90天且中间无≥90的值。

主要发现

  • 共识别11,240例CKD患儿(每10,000人15.7例),中位年龄11岁,50%为女性,中位随访5.1年(四分位距2.8-8.3),中位初始eGFR 75.3 ml/min per 1.73 m2(四分位距61-83),37%有蛋白尿,35%有高血压。
  • 与eGFR 60-89 ml/min per 1.73 m2相比,eGFR 45-59、30-44、15-29 ml/min per 1.73 m2的aHR分别为1.44(95%CI 1.23-1.69)、2.38(95%CI 2.02-2.79)、5.75(95%CI 5.05-6.55)。
  • 肾小球疾病aHR 2.01(95%CI 1.78-2.28),恶性肿瘤aHR 1.79(95%CI 1.52-2.11),蛋白尿aHR 2.23(95%CI 1.89-2.62),高血压aHR 1.49(95%CI 1.22-1.82),蛋白尿合并高血压aHR 3.98(95%CI 3.40-4.68)。
  • 复杂慢性共病数量每增加一个系统aHR 1.07(95%CI 1.05-1.10),男性aHR 1.16(95%CI 1.05-1.28),入组时年龄每增加一岁aHR 0.95(95%CI 0.94-0.96)。

关键数值与推荐

  • CKD进展定义为复合结局:eGFR<15 ml/min per 1.73 m2、eGFR下降≥50%、长期透析或肾移植。
  • 高血压定义为≥2次就诊有高血压诊断代码,蛋白尿定义为≥1次尿分析蛋白≥1+,均在入组后2年内评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objectives of this study were to use electronic health record data from a US national multicenter pediatric network to identify a large cohort of children with CKD, evaluate CKD progression, and examine clinical risk factors for kidney function decline. METHODS: This retrospective cohort study identified children seen between January 1, 2009, to February 28, 2022. Data were from six pediatric health systems in PEDSnet. We identified children aged 18 months to 18 years who met criteria for CKD: two eGFR values <90 and ≥15 ml/min per 1.73 m2 separated by ≥90 days without an intervening value ≥90. CKD progression was defined as a composite outcome: eGFR <15 ml/min per 1.73 m2, ≥50% eGFR decline, long-term dialysis, or kidney transplant. Subcohorts were defined based on CKD etiology: glomerular, nonglomerular, or malignancy. We assessed the association of hypertension (≥2 visits with hypertension diagnosis code) and proteinuria (≥1 urinalysis with ≥1+ protein) within 2 years of cohort entrance on the composite outcome. RESULTS: Among 7,148,875 children, we identified 11,240 (15.7 per 10,000) with CKD (median age 11 years, 50% female). The median follow-up was 5.1 (interquartile range 2.8-8.3) years, the median initial eGFR was 75.3 (interquartile range 61-83) ml/min per 1.73 m2, 37% had proteinuria, and 35% had hypertension. The following were associated with CKD progression: lower eGFR category (adjusted hazard ratio [aHR] 1.44 [95% confidence interval (95% CI), 1.23 to 1.69], aHR 2.38 [95% CI, 2.02 to 2.79], aHR 5.75 [95% CI, 5.05 to 6.55] for eGFR 45-59 ml/min per 1.73 m2, 30-44 ml/min per 1.73 m2, 15-29 ml/min per 1.73 m2 at cohort entrance, respectively, when compared with eGFR 60-89 ml/min per 1.73 m2), glomerular disease (aHR 2.01 [95% CI, 1.78 to 2.28]), malignancy (aHR 1.79 [95% CI, 1.52 to 2.11]), proteinuria (aHR 2.23 [95% CI, 1.89 to 2.62]), hypertension (aHR 1.49 [95% CI, 1.22 to 1.82]), proteinuria and hypertension together (aHR 3.98 [95% CI, 3.40 to 4.68]), count of complex chronic comorbidities (aHR 1.07 [95% CI, 1.05 to 1.10] per additional comorbid body system), male sex (aHR 1.16 [95% CI, 1.05 to 1.28]), and younger age at cohort entrance (aHR 0.95 [95% CI, 0.94 to 0.96] per year older). CONCLUSIONS: In large-scale real-world data for children with CKD, disease etiology, albuminuria, hypertension, age, male sex, lower eGFR, and greater medical complexity at start of follow-up were associated with more rapid decline in kidney function.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gluck CA, Forrest CB, Davies AG, et al. Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database. Clin J Am Soc Nephrol. 2023. PMID: 36754006. doi:10.2215/CJN.0000000000000051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。